In vitro complement activation by ragweed allergen extract in the sera of ragweed allergic and non-allergic persons

被引:18
作者
Hidvegi, T
Schmidt, B
Varga, L
Dervaderics, M
Lantos, A
Gonczi, Z
Barok, J
Otos, M
Kirschfink, M
Spath, P
Fust, G
机构
[1] NATL INST HAEMATOL & BLOOD TRANSFUS,H-1502 BUDAPEST,HUNGARY
[2] NUCL POWER STN LTD,HLTH CARE DEPT,PAKS,HUNGARY
[3] SEMMELWEIS UNIV MED,SCH MED,INST PULMONOL,BUDAPEST,HUNGARY
[4] UNIV HEIDELBERG,INST IMMUNOL,W-6900 HEIDELBERG,GERMANY
[5] ZLB,BERN,SWITZERLAND
[6] 18TH DIST GOVT HLTH CARE CTR,DEPT ALLERGOL ASTHMA,BUDAPEST,HUNGARY
关键词
complement activation; ragweed allergy; rhinoconjunctivitis; asthma bronchiale;
D O I
10.1016/0165-2478(95)02445-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ragweed allergen (RWA)-induced complement activation in sera of 40 RW allergic patients and of 40 non-allergic controls was investigated, After treatment of the sera with RWA, levels of C3a, C5a, C3bBbP, ClrClsClinh, SC5b-9 and granulocyte-aggregating activity were determined. Concentration of RW-specific IgG was also measured. After RWA treatment dose-dependent complement activation was detected in sera of RW allergic and non-allergic persons. C3a generation was observed mostly in the sera of RW allergic individuals, while levels of C3bBbP and of RW-specific IgG were significantly higher in sera of allergies, and a strong correlation was found between these two parameters. In a prospective clinical study, a significant positive correlation was observed between the extent of RWA-induced alternative pathway (AP) activation and the severity of symptoms of allergic rhinoconjunctivitis that were developed in a 4-week period subsequent to blood sampling. These observations suggest that complement activation has a role in the development of the symptoms of RW allergy.
引用
收藏
页码:65 / 71
页数:7
相关论文
共 37 条
[1]  
ARMSTRONG C, 1925, US PUBL HLTH REP, V40, P1466
[2]  
BERRENS L, 1978, ALLERGOL IMMUNOPATH, V6, P45
[3]   INTERLEUKIN-3 AND GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR RENDER HUMAN BASOPHILS RESPONSIVE TO LOW CONCENTRATIONS OF COMPLEMENT COMPONENT-C3A [J].
BISCHOFF, SC ;
DEWECK, AL ;
DAHINDEN, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) :6813-6817
[4]   COMPLEMENT ACTIVATION BY HOUSE DUST - REDUCED REACTIVITY OF SERUM COMPLEMENT IN PATIENTS WITH BRONCHIAL-ASTHMA [J].
CASTRO, FFM ;
SCHMITZSCHUMANN, M ;
ROTHER, U ;
KIRSCHFINK, M .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1991, 96 (04) :305-310
[5]   ELEVATED RELEASE OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERFERON-GAMMA BY BRONCHOALVEOLAR LEUKOCYTES FROM PATIENTS WITH BRONCHIAL-ASTHMA [J].
CEMBRZYNSKANOWAK, M ;
SZKLARZ, E ;
INGLOT, AD ;
TEODORCZYKINJEYAN, JA .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (02) :291-295
[6]  
CHAPEL H, 1984, ESSENTIALS CLIN IMMU
[7]  
CLOCK RO, 1917, J INFECT DIS, V21, P387
[8]   COMPLEMENT (C5A)-INDUCED GRANULOCYTE AGGREGATION INVITRO - POSSIBLE MECHANISM OF COMPLEMENT-MEDIATED LEUKOSTASIS AND LEUKOPENIA [J].
CRADDOCK, PR ;
HAMMERSCHMIDT, D ;
WHITE, JG ;
DALMASSO, AP ;
JACOB, HS .
JOURNAL OF CLINICAL INVESTIGATION, 1977, 60 (01) :260-264
[9]   THE PRIMING EFFECTS OF THE PRODUCTS OF STIMULATED MONONUCLEAR-CELLS ON THE RESPONSE OF NEUTROPHILS TO C5A DES ARG [J].
CROUCH, S ;
FLETCHER, J .
BRITISH JOURNAL OF HAEMATOLOGY, 1991, 77 (02) :158-164
[10]   FLUID PHASE GENERATION OF TERMINAL COMPLEMENT COMPLEX AS A NOVEL INDEX OF BIOINCOMPATIBILITY [J].
DEPPISCH, R ;
SCHMITT, V ;
BOMMER, J ;
HANSCH, GM ;
RITZ, E ;
RAUTERBERG, EW .
KIDNEY INTERNATIONAL, 1990, 37 (02) :696-706